Ankündigung

Einklappen
Keine Ankündigung bisher.

was es sonst noch so gibt

Einklappen
X
 
  • Filter
  • Zeit
  • Anzeigen
Alles löschen
neue Beiträge

  • was es sonst noch so gibt

    So, ich habe mal einen neuen Thread eröffnet, da wir das RFID, Fingerprint etc. also alles von mit Ident- Technik zu tun hat, nicht mit anderen Dingen belasten wollen.

    Somit hier in Zunkunft bitte alles rein, was interessant sein könnte.

    gruss
    mrasta

  • #2
    Hallo Meister Blackhead,

    war heute etwas zu spät dran in Berlin, da ich unerwartet weg musste. Konnte erst die Order gegen 13:30 reinstellen, aber 0,0 Erfolg. Werde es am Montag nochmal versuchen.
    Will da unbedingt rein, notfalls eben in HK.

    Sonotek hat es wohl einigen angetan, ich wäre da etwas vorsichtig. Weiß nicht wo da der große Sprung, bei dem jetzigen Kurs herkommen soll. Vielleicht durch die neue Linie, mag sein aber davon haben Sie erst 2 verkauft. Außerdem sind noch so still und heimlich rund 1,8 Mio Teile durch die Umwandlung einiger convert. debt dazugekommen. Viel falsch machen kann man wohl auch nicht, vielleicht zieht ihre neue Linie.

    MFIC muss man langfristig sehen, sonst wird man wahnsinnig. Dafür sind die Umsätze zu schwach und damit auch die Schwankungen einfach zu heftig. Sehe es genauso, mal abwarten was das Jahr und 2005 noch so bringt, muss man nicht jeden Tag nach dem Kurs schauen.

    Obdu, auch so ein Ding für sich. War da nur kurz drin, als Beckmann das Ding, wie auch immer, gefunden hat. War gutes, schnelles Geld. Nach diesem Chaos mit den Teilen, wer da nun wieviel bekommt oder auch nicht, kehrt ja so langsam wieder Ruhe ein. Die Technik als solche habe ich mir mehr als eingehend angesehen, rein Interesse halber. Und ich kann nur sagen, dass es völlig unklar ist, welche Technologie hier der Bringer für die Zukunft sein wird. Mann kann sich da ein paar Teile jetzt vielleicht wieder reinlegen, aber ich bin ab von dieser Welt. Gehe eher auf Werte die vielleicht nicht so den Hammer bringen, aber IMHO eine realistische Chance haben. Also lege Dir ein paar Teile rein, beruhigt auch das Gewissen.

    bis dann
    mrasta

    Kommentar


    • #3
      Tja Obducat.Also, mich nervt das ganze Bohai
      um die Firma. Die sind mir schlichtweg zu populär,und mittlerweile sagenhaft hoch bewertet.Es gab sogar am Freitag in der 3-Sat
      Börse eine Erwähnung,mit dem Verweis auf den hochspekulativen Charakter.Aber wie gesagt ich bleib da vorerst drin,solange die nicht charttechnisch einen Stock tiefer rauschen.Betrachte ich als wahrhaft langfristiges Invesment,womit mindestens 2-3 Jahre gemeint sind.Dann lässt sich sicherlich absehen ,ob die Nanolithographie die Chipherstellung revolutionieren wird,und ob OBDU da die Nase vorn hat.Ähnliches trifft auch auf JMAR zu.Von denen hab ich mich allerdings vorlaüfig erstmal getrennt,leider bevor die von ML geedelt wurden.
      Meine Order für den Hongkongplay steht für die gesamte nächste Woche mit Limit 0,04.
      Und vielen Dank für die Links
      Grübe BLACKHEAD

      Kommentar


      • #4
        Moin,

        bin nur kurz da, leider viel um die Ohren zur Zeit. Sehe aber zu, dass ich nachher noch die Order wieder reinbekomme für 0.04. Hat sich ja drüben ganz gut gehalten auf dem Niveau.

        bis dann
        mrasta

        Kommentar


        • #5
          Blackhead,

          wo steckt denn Deine Order. Habe meine mal bis Freitag reingestellt, da ich wieder ordentlich auf Achse bin und kaum Zeit habe.

          mal sehen
          mrasta

          Kommentar


          • #6
            AXM Pharma's Feminine Hygiene Product Approved by the National Ministry for Health and Hygiene in China

            Wednesday, April 28, 2004 09:17 ET

            NEWPORT BEACH, CA, Apr. 28, 2004 (MARKET WIRE via COMTEX) -- AXM Pharma, Inc. (AMEX: AXJ) announced today that the Company has received approval from the National Ministry for Health and Hygiene in China to begin manufacturing and distribution of its newest feminine hygiene product, Xin Shu. The approval demonstrates AXM Pharma's continued commitment to becoming a leader in the fast-growing over-the-counter ("OTC") and generic Pharmaceutical market in China. Xin Shu is a proprietary product made with 10 herbal extracts and having a pleasant apple fragrance. It has been approved as an adjunctive therapy for prevention of mild to moderate bacterial and viral vaginal infection and relief of vaginal itch from nonspecific causes. Xin Shu is AXM Pharma's first product targeting the vaginal itch and vaginal infection segment of the Chinese OTC market. In 2003, this segment accounted for sales of over $US500 million and its growth outpaced the overall rate for the entire OTC market.

            "The introduction of Xin Shu is another important step in our strategy of increasing revenue by launching new in-license products in targeted markets," said Peter Cunningham, president and CEO of AXM Pharma, Inc. "We believe that our strengths in manufacturing and distribution in China, combined with our focus on introducing new products, will continue to allow us to rapidly increase revenue and market share."

            The Company is currently conducting production scale-up and stability testing trials, with the expectation of launching the product within 90 days. Saatchi & Saatchi and Highlight Charm (a Beijing based agency) are the finalists for appointment as the advertising agency for Xin Shu. AXM Pharma is currently negotiating with two of China's largest distributors for appointment as distributors for Xin Shu.

            "AXM Pharma is continuing to improve our product line and distribution network," continued Mr. Cunningham. "Xin Shu is another example of our continued commitment to sales and market expansion."

            AXM Pharma Inc., http://www.axmpharma.com, through its wholly owned subsidiary, Werke Pharmaceuticals, Inc., is the 100% owner of Shenyang Tianwei Werke Pharmaceutical Co., Ltd. ("STWP"), a Wholly Foreign Owned Enterprise ("WFOE") under the laws of the People's Republic of China. STWP is located in the City of Shenyang, in the Province of Liaoning, China. STWP and its predecessor company Shenyang Tianwei Pharmaceutical Factory, Ltd. ("STPF"), has an operating history of approximately 10 years. STWP historically has been a manufacturer and distributor of proprietary and generic pharmaceutical products, which include injectables, capsules, tablets, liquids and medicated skin products for export and domestic Chinese sales. Axiom currently out-sources production and distribution of its products to third parties in China.

            Kommentar


            • #7
              Servus MRASTA,
              hab mir dummerweise beim Badminton einen Supergau im Knie eingehandelt(Churchill hatte wohl doch recht).Habe somit eine unfreiwillige neue Hauptbeschäftigung:Reha!
              Da die U`s in Berlin reichlich zementiert sind,habe ich meine Order vorläufig zurückgezogen.Bin aber auf jeden Fall dabei,sobald sich was regt.
              Stattdessen hoffe ich bei Bio-key mit einem Abstauberlimit doch noch zum Zug zu kommen.Glaube auch ,daß da der eigentliche Hype noch bevorsteht.
              Vielleicht riskierst du auch mal einen Blick auf Atlas Mining.Nach jüngsten Kooperationsverhandlungen ein halber Nanostock,und durchaus eine Beobachtung wert.
              Ach ja,und bei ISON scheint langsam wirklich was zu gehen...
              Ahoi und bis bald
              BLACKHEAD

              Kommentar


              • #8
                Ja,ja
                AXM macht sich .Jetzt fehlt nur noch der Diabetesmarkt und das Glück ist perfekt.
                Da kann man im Moment eigentlich nichts verkehrt machen ,denn bei 4$ scheint tatsachlich der Boden zu sein.Könnte man durchaus nochmal nachlegen.Was meinst du?
                Bist du überhaupt schon drin?

                Kommentar


                • #9
                  Jo, recht haste. Bio-Key und auch diverse andere mussten ganz schön Federn lassen. Wie dem auch sei, bei einigen, und hierzu zähle ich auch Bio-key, war einen Einstieg um und bei 1.60 die Sache wert, IMHO.

                  Ist schon erstaunlich wer sich hier wo verabschiedet. Ist mir, ehrlich gesagt, schnuppe.

                  Aber eine ganz andere Geschichte könnte auch uns betreffen, bzw. die Berlinerbörse. Shit sitze gerade am Laptop, da habe ich nicht den richtigen Verweiws, poste es Morgen. Ist aber schon eine heftige Geschichte.

                  Es wird behauptet, das Stocks an der Berliner Börse gelistet werden, obwohl die Frimen gar nichts davon wußten. Oder haste schonmal einen Hinweis bei unserem Teil in der Hinsicht gelesen ? Könnte hier also genauso gelaufen sein.

                  Sehe mal zu, dass ich Morgen wieder daran komme.

                  cu

                  Kommentar


                  • #10
                    wau, 23:00 Uhr, dabei dachte ich es wäre es so kurz nach 6 . ;-)))

                    Scheint wohl im Internet einiges durcheinander zugehen. W:O ist schon seit Stunden nicht mehr zu erreichen.

                    Wie dem auch sei, denke mal, wir sind gut dabei. In diesem Sinne.

                    mrasta

                    Kommentar


                    • #11
                      Oh je, jetzt geht es so richtig ab. Schaue mal bei meinem anderen Thread vorbei, Fingerprint etc. Ich habe es schon befürchtet, aber ich denke, das ist nur die Spitze des Eisberges. Sieht für die Berliner überhaupt nicht gut aus.

                      Meine Order war bis Freitag terminiert, wie sieht es bei Dir aus ? Wenn, dann mal lieber raus damit. Da von U-? auch noch keine Info vorliegt in Hinsicht auf die Berliner. Mann oh, mann mit was man sich alles beschäftigen muss, unglaublich.

                      cu

                      Kommentar


                      • #12
                        Hi MRASTA,
                        Wie gesagt,meine Order hab ich aufgrund des Zementsockels bei 0,065 voerst gestrichen.
                        Tja,weiß auch nicht ,was mit den Berlinern los ist.Einen ähnlichen Vorfall gab`s doch erst jüngst bei AMBRI,soviel ich weiß.Sind denn außer Advanced noch andere betroffen?
                        Anbei noch ein paar News von MFIC.Da könnte man langsam mal nachladen(2.25$!)
                        Und bist du nun bei AXM dabei,oder wartest du noch den Wonnemonat ab und hoffst auf einen billigeren Einkauf?So oder so Alles Gute BLACKHEAD
                        Webcast Alert: Biophan Technologies, Isonics Corp., MFIC and Molecular Imaging to Present at Trilogy Capital's Online Nanotechnology Forum on Friday, May 7, 2004
                        Thursday April 29, 8:00 am ET
                        Online Conference to Focus on Scientific Breakthroughs in Burgeoning Nanotech Industry

                        LOS ANGELES--(BUSINESS WIRE)--April 29, 2004-- Trilogy Capital Partners, Inc. announced today that it is sponsoring an online Nanotechnology conference on Friday May 7th at 12 pm Eastern. The conference, Trilogy Capital's Online Nanotechnology Forum, will feature five emerging growth Microcap public companies excelling in nanotechnology and related markets. The current schedule of presenting companies is: Biophan Technologies, Inc. (OTC BB: BIPH - News), Isonics Corporation (NASDAQ: ISON - News), MFIC Corporation (OTC BB: MFIC - News) and Molecular Imaging Corporation (OTC BB: MLRI - News).

                        "The companies which occupy the nanotech universe represent the cutting edge of the future of science as nanotechnology moves from the laboratory into the mainstream," stated A.J. Cervantes, president of Trilogy and forum moderator. "For those investors who are interested in nanotechnology, this forum represents the opportunity to meet the senior management of five potentially high-growth companies in a convenient, fast-paced 30 minute presentation. We encourage investors and other interested parties to visit www.trilogy-capital.com to learn more about these excellent companies."

                        What: Biophan Technologies, Isonics Corporation, MFIC
                        Corporation and Molecular Imaging to Present at Trilogy
                        Capital Partners' inaugural Online Nanotechnology Forum.
                        More companies are expected to be announced in the coming
                        days.

                        Who: Conference Moderator: A.J. Cervantes, President - Trilogy
                        Capital Partners, Inc. Keynote speaker to be announced.

                        When: Friday, May 7, 2004 12:00PM Eastern

                        Where: Please register at www.trilogy-capital.com.
                        Pre-registration is required.

                        Cost: The conference is completely free of charge.

                        How: Live over the Internet - registered attendees will
                        receive instructions via email prior to the event.

                        Archive: If you are unable to participate during the live
                        webcast, the Forum will be archived for replay at
                        www.trilogy-capital.com.

                        Biophan Technologies, Inc. (OTC BB: BIPH - News) Committed to growth through innovation and developmental leadership, Biophan and its licensors have nine issued U.S. patents and over fifty patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com.

                        Isonics Corporation (NASDAQ: ISON - News) is divided into two segments: (1) Isonics Semiconductor and (2) Isonics Life Sciences. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. For more information: www.isonics.com.

                        MFIC Corporation (OTC BB: MFIC - News), through its Microfluidics Division, provides patented and proprietary, high performance Microfluidizer® materials processing equipment to the pharmaceutical, biotechnology, chemical, cosmetic/personal care, and food processing industries. To find out more about MFIC, visit its website at www.mfics.com.

                        Molecular Imaging Corporation (OTC BB: MLRI - News) is a leading national service provider of Positron Emission Tomography ("PET") diagnostic imaging services. The Company operates both mobile and permanent (fixed) PET imaging technologies for hospitals, diagnostic imaging centers and physician group practices offices across the U.S. www.molecularimagingcorp.com.

                        About Trilogy Capital Partners

                        Trilogy Capital Partners is a Los Angeles-based financial services company engaged in merchant banking, strategic planning, financial marketing and communications. Based on the simple concept that many well-run public companies are not realizing their full value in the marketplace, Trilogy has aggregated highly experienced executives into a formidable financial and marketing team, which help investors identify and maximize prospective high-return opportunities. Trilogy is committed to identifying companies with strong management, a compelling business model and, most importantly, companies that may be seriously undervalued. For more information on Trilogy, or its portfolio clients, please visit www.trilogy-capital.com.

                        Contact:
                        Trilogy Capital Partners, Inc.
                        Executive Vice President
                        Michael Briola, 800-251-1770
                        michael@trilogy-capital.com

                        Source: Trilogy Capital Partners, Inc.

                        Wall Street Reporter Issues a New Interview With MFIC CEO, Irwin Gruverman
                        Thursday April 29, 4:28 pm ET
                        Full Interview Available at WSR Website

                        NEWTON, Mass.--(BUSINESS WIRE)--April 29, 2004--At the request of the Wall Street Reporter Magazine, Irwin Gruverman, CEO and Chairman of MFIC Corporation (OTCBB: MFIC - News) was interviewed by Scott Banks on the subject of MFIC's recent completion of its successful financial restructuring and its ongoing contribution to American manufacturing excellence in a range of products. MFIC provides the leading edge high performance mixing and formulation equipment available to the biotech, pharmaceuticals, coatings, paint, chemical and food industries.

                        The interview can be heard online at www.wallstreetreporter.com and serves to familiarize investors with MFIC, giving them insight into the background, performance, products and management team of the Company. The in-depth interviews conducted by WSR are geared toward sophisticated investors who require unbiased, unscripted first-hand perspective to assist them in making informed investment decisions. The interview can be retrieved on the site by scrolling down the right-hand column of companies covered until you locate MFIC which is listed under the OTCBB section.

                        Mr. Gruverman focussed on the financial re-engineering of MFIC which occurred in the last few months. As described in recent press releases, the Morehouse-COWLES Division assets were sold to allow a focus on the core Microfluidizer systems business; restructured bank lines moved from an asset-based line which limited investment in new initiatives to a four-year term loan and cash-flow based credit line; a completed a PIPE financing to raise $2.9MM net, with Warrants outstanding now which could raise an additional $3MM. The company is now out of debt and can commit more than $2MM to new initiatives.

                        Proceeds will be committed to several programs. Mr. Gruverman stated "We have hired and will continue to seek key people in engineering, marketing/sales and R&D functions. We are initiating several exciting projects using our Multiple Stream Mixer/Reactor (MMR) technology, and plan a multi-year effort to establish MFIC as the leader in nanotechnology materials manufacturing. Marketing and development of systems and applications will be included in this effort.

                        Our core Microfluidizer® processing system business will commit to increase our market penetration from the few percent we now enjoy to several times that level. We plan to have industry specialists to find applications in many industries for our unique high pressure fluid processing technology."

                        The Board of Directors includes individuals with banking, marketing, technical and financing expertise and is active in enhancing a skilled management team in its performance.

                        Marketing and sales are centralized and a strong core team leads an extensive network of agents and distributors in North America, Europe and Asia. About 80% of Microfluidizer processor system sales are to the pharmaceutical and biotech industries. Most sales are to Fortune 500 companies.

                        "We have restarted our Investor Relations efforts to create an awareness of our new position as a financially-sound business with a strong core and a new proprietary MMR component with the potential to propel us to a much higher value level over time," commented Mr. Gruverman. "We are seeking to resume listing on a National exchange."

                        Management believes that this release contains forward-looking statements that are subject to certain risks and uncertainties including statements relating to the Company's ability to achieve attain and/or increase operating profitability, and/or to achieve and/or improve net income profitability. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results achieved by the Company to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that the actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including but not limited to, the following risks and uncertainties: (i) whether the performance advantages of the Company's Microfluidizer® materials processing equipment will be realized commercially or that a commercial market for the equipment will continue to develop, (ii) whether the Company will have access to sufficient working capital through continued and improving cash flow from sales and ongoing borrowing availability, the latter being subject to the Company's ability to comply with the covenants and terms of the Company's loan agreement with its senior lender, and (iii) whether the Company will be able to produce and make timely delivery of equipment under accepted purchase orders and outstanding sales quotations.

                        MFIC CORPORATION

                        MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer® materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for nanoparticle products for more than 15 years. The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.

                        Contact:
                        MFIC Corporation
                        Robert P. Bruno, President & COO
                        or
                        Irwin Gruverman, CEO & Chairman
                        or
                        Jack M. Swig, Investor Relations
                        617-969-5452
                        info@mfics.com
                        www:mficcorp.com

                        Kommentar


                        • #13
                          Ach ja,ich vergaß zu erwähnen,dass ich bei Bio-key eingetreten bin.Für 1,62 wurde ich reingelassen.N´bischen spät vielleicht ,aber bei weitem nicht zu spät.
                          Und dann möcht ich doch noch mal beim Thema Internet-Telefonie nachhaken.Zweifellos,da wirst du mir sicher zustimmen,ein Markt der kommenden Jahre.Nettel hatte ich in diesem Zusammenhang ja schon mal kurz erwähnt.Aber wer sind die Big-Player?Net2phone oder ITXC vielleicht.Sind kursmäßig zumindest am Boden.Könnten auf lange Sicht ganz gute Einstandskurse sein.Oder glaubst du ,dass es verfrüht ist,sich heuer mit diesem Trend zu beschäftigen?

                          Kommentar


                          • #14
                            Hi Blackhead,

                            sehr unschöne Geschichte mit den Berlinern, könnte eine ganze Lawine auslösen. Weiß nicht, wie das rein rechtlich zu bewerten ist. Logisch scheint mir, dass die nicht einfach ohne Wissen der Firmen hier einfach ein Listing durchführen können oder doch ?

                            Ist ein heißes Eisen. Insofern lieber erstmal vorsichtig, nicht, dass man die Teile dann hier nicht losbekommt. Ja, sind noch andere betroffen.

                            AXM bin ich drin, erstmal mit einer kleineren Menge. Denke auch die 4 sollte halten, wenn nicht, nachkaufen. Bio-Key, war eine gute Gelegenheit, denke ich mal. Genauso wie AIDO, merkwürdig dieser Kurs.

                            cu


                            Article from FincialWire

                            StockGate: Berlin Stock Exchange Admits to ‘Unauthorized’ Listings of U.S. Companies / FinancialWire®

                            April 29, 2004. (FinancialWire) Officials of the Berlin Stock Exchange have confirmed to FinancialWire that U.S. public companies have been listed for trading without their knowledge or authorization, but denies that the purpose was to circumvent the new NASD rules that require U.S. brokers to gain assurances of “affirmative determinations” from short sellers in both the U.S. and abroad.

                            At the same time, BGR (OTCBB: BGRR) stated it is one of those victimized, and that it is asking for “immediate removal.” Berliner Freiverkehr (Aktien) AG has been singled out as the broker and market maker that has been listing such companies as Zaldiva (OTCBB: ZLDV). Others, such as XRAYMEDIA Inc. (OTCBB: XRYM), and ICOA, Inc. (OTCBB: ICOA), have actually embraced their listings.

                            Naked short-selling opponents are claiming that “the Berlin Stock Exchange” has listed upwards of 30% of the approximately 100 companies listed by FinancialWire as having been potential targets of naked short-selling in the U.S., apparently without their permission or authorization.

                            U.S. companies supposedly were no longer under the spell of manipulative trading due to changes in regulations some three weeks ago requiring U.S. brokers to refuse orders from Canadian and other brokers without a sure-fire “affirmative determination.” An exception to the short-selling rule is “arbitrage,” which can be accomplished when a company lists on more than one exchange.

                            Friederike von Hofe, lawyer for the Berlin Stock Exchange, denied to FinancialWire in an exclusive interview that the istings provide cover for stock manipulation.

                            “First of all, price manipulation is a punishable act by German Criminal law. This does cover all exchange trading, so that manipulative trades in OTC-BB companies also constitute a criminal act. The price fixing process for the OTC-BB companies is the same as for any other security traded on our exchange. All prices fixing is supervised by our market surveillance and by our regulator, again, including price fixing for OTC-BB companies.”

                            Von Hofe stated that the companies in question “were listed by one of our brokers as an offer to German
                            investors. Trading foreign securities on foreign exchanges involves very high fees rised by the banks. Therefore, German investors make use of this offer, thus avoiding the high fees. The broker who applied for trading the OTC-BB companies certainly did not ‘list’ them to circumvent US-regulations.

                            “Legally, the companies don't have a right of objection to being traded on our exchange. As a matter of fact, if companies ask to be delisted, our broker will ask for a delisting and we will act accordingly,” von Hofe promised.

                            “Currently there are about 10.000 foreign stocks traded on our exchange. This includes almost all NASDAQ-listed stocks and many NYSE-listed stocks. Until now we faced no problems at all with this. We also received positive reactions from companies that were included into trading only recently.”
                            The exchange attorney confirmed that some companies wished to be delisted, and that “trading was stopped for all companies requesting it.”

                            C. Austin Burrell, who consults to several companies on the short-selling issue, responded that no company should be denied the right choose where its securities are traded. Further, any Company would want to know that when markets are made in its securities, that relevant US laws and regulations would be complied with.
                            “There is plentiful evidence that when US securities are traded by non-US persons offshore, they feel no compunction to comply with applicable US laws. Foreign abuses of regulations surrounding short sales are legendary, and they impact the credibility of financial statements and reporting,” said Burrell.

                            “Since no application is requested nor is any consent, how are stocks chosen for trading? What is the interest or motive of the broker in requesting trading in a specific security ? Why are so many stocks that have major naked short positions selected for trading over others?” he asked.BGR, in fact, stated that “during the past several weeks the company's share price has suffered. Management believes that the persistent pressure on the share price, in the face of numerous positive corporate developments, may be related to the erroneous listing on the Berlin Stock Exchange.” Zaldiva, on the other hand, enumerated the reasons it is embracing its listing on the exchange:

                            “1-German investors, including small ones, can buy Zaldiva in their domestic currency;
                            “2-Transaction are easier for people outside North and South America;
                            “3-Easier access of news on Zaldiva for the foreign markets; and
                            “4-Attracts a lot of publicity worldwide.
                            ''We take pleasure in having found such a competent partner in Zaldiva to accompany onto the Berlin Stock Exchange,''

                            said a spokesperson for Berliner Freiverkehr (Aktien) AG. The broker said it has “dual-listed over 6,800 foreign equities in Berlin with trading volume of over 11 billion Euro in the OTC market in Berlin.”
                            Recently, renowned columnist, Jack Anderson, who writes the “Washington Merry-Go-Round,” alleged that much of the naked short selling in small cap stocks drains small U.S. companies of their market caps and their small investors of their nest-eggs specifically to funnel money into terrorist hands, a sort of double-whammy against the American capitalist system.

                            “The USA Patriot Act, adopted in October 2001, expanded the scope of U.S. money-laundering rules in order to make it harder for terrorists to move money without attracting attention. It includes beefed-up know-your-customer requirements for some financial institutions, according to some legal experts” said the U.S. financial newspaper.

                            Recently, leading market makers and brokers named in various lawsuits and other actions, including FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion’s (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), were given a “reprieve” were forced to comply with new short-selling market regulations imposed by the NASD after the SEC had “sat on” the NASD request to plug material loopholes for almost 2-1/2 years.

                            “The new rules expand the scope of the affirmative determination requirements to include orders received from broker/dealers that are not members of NASD (''non-member broker/dealers'').
                            The new rule is on the web at http://www.nasdr.com/2610_2004.asp #04-03
                            The rule itself, while welcomed by small companies and their shareholders in the U.S., nevertheless raised an outcry because the NASD’s request to put it into effect had set on a shelf at the SEC since 2001.
                            Recent wrist slaps have involved Falcon Research, Inc., fined $10,000, SG Cowen Securities Corporation, fined $230,000, and Sterne, Agee & Leach, Inc., fined $35,000.

                            Meanwhile, CBS Marketwatch, a venture between Marketwatch (NASDAQ: MKTW) and Viacom’s (NYSE: V) CBS unit, has suggested that victims of securities fraud may be able to file for theft claims on tax returns instead of capital losses. The scandal has embroiled hundreds of companies and dozens of brokers and marketmakers, in a web of internaitional intrigue, manipulative short-selling and cross-border accusations and denials. Comments on Regulation SHO ended January 5, and may be viewed at http://www.sec.gov/rules/proposed/s72303.shtml .
                            Some 122 companies, including 13 brokers, such as FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion’s (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), have been embroiled for over a year in a raging controversy
                            The remaining 109 companies among the 122 named to date have issued press releases or been named in the media as having been victimized, or as taking various actions, either alone or in concert with other companies, to oppose manipulative trading in the form of illegal naked short selling. The actions have ranged from lawsuits to withdrawals and threatened withdrawals from the electronic trading system managed by the Depository Trust & Clearing Corp., to withdrawals from toxic financings, to the issuance of dividends or name changes designed to squeeze manipulators, to joining associations or networks or to contacting regulatory authorities to provide documentation of abuses or otherwise complain.
                            The complete list of those 108 companies include Advanced Viral Research Corp. (OTCBB: ADVR), AdZone Research, Inc. (OTCBB: ADZR), Amazon Natural Treasures (OTC: ANTD), America's Senior Financial Services (OTCBB: AMSE), American Ammunition, Inc. (OTCBB: AAMI), AngelCiti Entertainment (OTCBB: AGLC), ATSI Communications, Inc. (OTC: ATSC), Federal Agricultural Mortgage / Farmer Mac (NYSE: AGM) Allied Capital (NYSE: ALD), American Motorcycle (OTC: AMCYV), American International Industries (OTCBB: AMIN), Ameri-Dream (OTC: AMDR), Adirondack Pure Springs Mt. Water Co. (OTCBB: APSW), ATSI Communications, Inc. (OTC: ATSC) Bluebook International (OTCBB: BBIC), Blue Industries (OTCBB: BLIIV), Bentley Communications (OTCBB: BTLY), BIFS Technologies Corporation (OTCBB: BIFT), Biocurex (OTCBB: BOCX). Broadleaf Capital Partners, Inc. (OTCBB: BDLF), Chattem, Inc. (NASDAQ: CHTT), Critical Home Care (OTCBB: CCLH), Composite Holdings (OTC: COHIA), CyberDigital, Inc. (OTCBB: CYBD). Diamond International Group (OTCBB: DMND), Dobson Communications Corp. (NASDAQ: DCEL), Eagle Tech Communications (OTC: EATC), Edgetech Services (OTCBB: EDGH);
                            Also, Endovasc Ltd. (OTCBB: EVSC), Enviro-Energy Corporation (OTCBB: ENGY), Environmental Products & Technologies (OTC: EPTC), Environmental Solutions Worldwide, Inc. (OTCBB: ESWW), EPIXTAR Corp. (OTCBB: EPXR), eResearchTechnologies, Inc. (NASDAQ: ERES), Flight Safety Technologies (OTCBB: FLST), Freddie Mac (NYSE: FRE), FreeStar Technologies (OTCBB: FSRCE), Front Porch Digital,
                            Inc. (OTCBB: FPDI), Geotec Thermal Generators, Inc. (OTCBB: GETC), Genesis Intermedia (OTC: GENI), GeneMax Corp. (OTCBB: GMXX), Global Explorations Inc (OTC: GXXL), Global Path (OTCBB: GBPI), GloTech Industries, Inc. (OTCBB: GTHI), Green Dolphin Systems (OTCBB: GLDS), Group Management (OTCBB: GPMT), Hop-On (OTC: HPON), H-Quotient, Inc., (OTCBB: HQNT), Hyperdynamics Corp. (OTCBB: HYPD), International Biochem (OTCBB: IBCL), Intergold Corp. (OTCBB: IGCO), International Broadcasting Corporation (OTCBB: IBCS), InternetStudios, Inc. (OTCBB: ISTO), ITIS Holdings (OTCBB: ITHH), Investco Corp. (OTCBB: IVCO), Lair Holdings (OTC: LAIR), Lifeline BioTechnologies Inc. (OTC: LBTT), Life Energy & Technology (OTCBB: LETH), MBIA (NYSE: MBI);
                            Also, MegaMania Interactive (OTC: MNIA), MetaSource Group, Inc. (OTCBB: MTSR), Midastrade.com (OTC: MIDS), Make Your Move (OTCBB: MKMV), Medinah Minerals (OTC: MDMN), MSM Jewelry Corp. (OTC: MSMC), Nanopierce Technologies, Inc. (OTCBB: NPCT), Nutra Pharmaceutical (OTCBB: NPHC), Nutek (OTCBB: NUTK), Navigator Ventures (OTC: NVGV), Orbit E-Commerce, Inc. (OTCBB: OECI), Pitts & Spitts (OTC: PSPP), Sales OnLine Direct (OTCBB: PAID), Pacel Corp. (OTCBB: PACC), PayStar Corporation (OTC: PYST), Petrogen Corp. (OTCBB: PTGC), Pinnacle Business Management (OTC: PCBM), Premier Development & Investment, Inc. (OTCBB: PDVN), PrimeHoldings.com, Inc. (OTC: PRIM), Phlo Corporation (OTCBB: PHLC), Resourcing Solutions (OTC: RESG), Reed Holdings (OTC: RDHC), Rocky Mountain Energy Corp. (OTCBB: RMECE), RTIN Holdings (OTCBB: RTNHE), Saflink Corp. (NASDAQ: SFLK), Safe Travel Care (OTCBB: SFTVV), Sedona Corp. (OTCBB: SDNA);
                            Also, Sionix Corp. (OTCBB: SINX), Sonoran Energy (OTCBB: SNRN), Starmax Technologies (OTC: SMXIF), Storage Suites America (OTC: SSUA), Suncomm Technologies (OTC: STEH), Sports Resorts International (NASDAQ: SPRI), Technology Logistics (OTC: TLOS), Swiss Medica, Inc. (OTCBB: SWME), Ten Stix, Inc. (OTCBB: TNTI), Tidelands Oil (OTCBB: TIDE), Titan Construction (OTC: TTCS), Trezac Corp. (OTCBB: TRZAV), Universal Express, Inc. (OTCBB: USXP), Valesc Holdings, Inc. (OTCBB: VLSHV), Vega Atlantic (OTCBB: VGAC), Viragen (AMEX: VRA), Viragen International (OTCBB: VGNI), Vista Continental Corporation, (OTCBB: VICC), Viva International (OTCBB: VIVI), Vtex Energy (OTCBB: VXENE) and Wizzard Software (OTCBB: WIZD), WorldTradeShow.com (OTC: WTSW) and Y3K Secure Enterprise Software, Inc. (OTCBB: YTHK).
                            Earlier in 2003, the SEC fined Rhino Advisors, Inc., $1 million for its representation of Amro International in the financing and manipulation of Sedona Corp. Amro, also known as AMRO, was registered in Panama, a secretive offshore haven, but was not named in the SEC settlement. Another 60 public companies may have been manipulated by the fined Rhino Advisors and its indicted principals, or its funding apparatus, Amro.
                            These include:
                            All American Food Group Inc (OTC: AAFGQ), Amanda Co Inc (OTC: AMNA), Antra Holdings (OTC: RECD), Aquis Communications Group Inc (OTCBB: AQUIS), Avanir Pharmaceuticals (AMEX: AVN), Bionutrics Inc (OTC: BNRX), Brilliant Digital Entertainment Inc (AMEX: BDE), Bravo! Foods International Corp. (OTCBB: BRVOE), Butler National Corp (NASDAQ: BUTL), Calypte Biomedical Corp (OTCBB: CYPT), Chemtrak Inc/DE (OTC: CMTR), Clicknsettle Com Inc (OTCBB: CLIK), Corporate Vision Inc (OTC: CVIA), Crown Laboratories Inc/DE (OTC: CLWB), Dental Medical Diagnostic Systems Inc (OTC: DMDS), Detour Media Group Inc (OTC: DTRM),
                            Also, Digital Privacy Inc/DE (OTC: DGPV), Senior Services Inc (OTC: DISS), International Inc (OTC: DYNX), Endovasc Ltd Inc (OTCBB: EVSC), Esynch Corp/CA (OTCBB: ESYN), Focus Enhancements Inc (NASDAQ: FSCE), Frederick Brewing Co (OTC: FRBW), Greystone Digital Technology Inc (OTC: GSTN), Havana Republic Inc/FL (OTCBB: HVNR), Henley Healthcare Inc (OTC: HENL), Hollywood Media Corp (NASDAQ: HOLL), Ibiz Technology Corp (OTCBB: IBZT), Diagnostic Systems Inc/FL (OTCBB: IMDS), Imaging Technologies (OTCBB: IMTO), Integrated Surgical Systems Inc (OTCBB: RDOC),
                            Also, Interferon Sciences Inc (OTC: IFSC), Interiors Inc (OTC: ITRNA), Laminaire Corp (OTC: THMZ), Medisys Technologies Inc (OTC: SCEP), Milestone Scientific Inc/NJ (AMEX: MS), Nevada Manhattan Group Inc (OTC: NVMH), Innovations Inc (OTCBB: NTGE), Systems Group (OTC: OSYM), Pacific Systems Control Technology Inc (OTCBB: PFSY), Professional Transportation Group Ltd Inc (OTC: TRUC), Rnethealth Inc (OTC: RNTT),
                            Also, Sand Technology Inc (NASDAQ: SNDT), Sedona Corp (OTCBB: SDNA), Silverado Foods Inc (OTC: SVFO), Stockgroup Information Systems (OTCBB: SWEB) Surgilight Inc (OTC: SRGL), Tasty Fries Inc (OTCBB: TFRY), Tech Laboratories Inc (OTCBB: TCHL), Teltran International Group Ltd (OTC: TLTG), Titan Motorcycle Co of America Inc (OTC: TMOTQ), Trans Energy Inc (OTCBB: TSRG), Motorcycle Co (OTC: UMCC), Universal Communication Systems Inc (OTCBB: UCSY), Medical Systems Inc (OTC: UMSI), Vianet Technologies Inc (OTC: VNTK),Viragen Inc (AMEX: VRA), Webcatalyst Inc (OTC: WBCL), Worldwide Wireless Networks Inc (OTCBB: WWWNQ), and ZAP (OTCBB: ZAPZ).



                            << previous Message



                            [Dieser Beitrag wurde von mrasta am 03.05.2004 editiert.]

                            Kommentar


                            • #15
                              und nun ?

                              Ordern in HK, oder wie ? Das Teil scheint bei 0.37 erstmal festgenagelt. Wäre doch ein guter erster Einstieg. Mal sehen was die DAB für einen Handel da verlangt.

                              cu

                              Kommentar

                              Lädt...
                              X